World-first gonorrhoea vaccine programme set to be rolled out
The move, hailed as a 'landmark moment for sexual health', will aim to tackle rising levels of the sexually transmitted infection (STI).
It comes after the number of gonorrhoea cases in England topped 85,000 in 2023, the highest since records began in 1918, with warnings over some strains being resistant to antibiotics.
Gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI will be eligible under the new programme, NHS officials said.
According to the Joint Committee on Vaccination and Immunisation (JCVI), gonorrhoea disproportionately impacts specific communities, such as deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men.
Diagnoses are highest among gay, bisexual and other men who have sex with men, the JCVI said.
UK Health Security Agency (UKHSA) data shows there was a 9.4% increase in gonorrhoea diagnoses among gay, bisexual and other men who have sex with men in 2023, with cases rising from 37,095 to 40,586.
The vaccine is an existing jab, known as 4CMenB, that is currently used to protect people against the meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis.
It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year.
Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The launch of a world-first routine vaccination for gonorrhoea is a huge step forward for sexual health and will be crucial in protecting individuals, helping to prevent the spread of infection and reduce the rising rates of antibiotic resistance strains of the bacteria.'
Eligible patients will be identified and contacted in the coming weeks, with the jab offered through local authority-commissioned sexual health services from August 1.
And while at the appointment, patients will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B.
Dr Doyle added: 'NHS teams across the country are now working hard to plan the rollout and ensure we hit the ground running, while the routine mpox vaccination programme builds on the vital progress the NHS has made in recent months in reaching as many eligible people as possible.'
Gonorrhoea is the second most common bacterial STI in the UK.
Symptoms can include green or yellow discharge from the vagina or penis, pain when urinating and pain and discomfort in the rectum.
For women, symptoms can include lower abdominal pain or bleeding between periods.
However, many people do not have symptoms.
The jab contains proteins from neisseria meningitidis – the bacteria that causes meningococcal disease – which is closely genetically related with neisseria gonorrhoeae, the bacteria that causes gonorrhoea.
The JCVI said studies suggest the 4CMenB vaccine has between 32.7 to 42% effectiveness against gonorrhoea, and while vaccination would slash the risk of becoming infected it would not eliminate it completely.
However, it stressed that vaccination would be beneficial, as previous gonorrhoea infection is thought to offer little protection against future infections.
The programme comes amid warnings that cases of gonorrhoea that are resistant to the antibiotic ceftriaxone – usually the first line of treatment – are on the rise in England.
This means the bacteria that causes the STI has developed the ability to survive and multiply even when exposed to the antibiotic.
Some cases are also classed as 'extensively drug resistant' – or XDR – meaning the infection did not respond to ceftriaxone or the second line of treatment.
In March, UKHSA revealed there were 17 cases of ceftriaxone-resistant gonorrhoea between January 2024 and March 2025.
In the same period, there were nine XDR cases reported, compared to five cases between 2022 and 2023.
Dr Sema Mandal, consultant epidemiologist and deputy director at UKHSA, said: 'This vaccination programme is a hugely welcome intervention at a time when we're seeing very concerning levels of gonorrhoea, including antibiotic resistant gonorrhoea.
'In 2023 we saw gonorrhoea diagnoses reach their highest since records began in 1918.
'Not only will this roll-out provide much needed protection to those that need it most, but it will make the UK the first country in the world to offer this protection and a world leader in protecting people against gonorrhoea.'
Health minister Ashley Dalton urged people to take up the vaccine offer 'not only keep each other safe but help tackle the growing threat of antibiotic resistance'.
She added: 'By targeting those most at risk, we can reduce transmission rates from this unpleasant disease that is becoming harder to treat and prevent thousands of cases over the next few years.'
Richard Angell, chief executive of Terrence Higgins Trust, described the jab as a 'game changer'.
'This alone could cut 40% of new gonorrhoea cases,' he said.
It comes after 12 new mpox vaccination sites opened across England in February, meaning every area in the country can now offer jabs to those at a higher risk of getting the virus.
Previously, vaccines were only available to eligible people at 19 sites across London, Brighton in East Sussex, and Manchester.
Professor Matt Phillips, president of the British Association for Sexual Health and HIV (BASHH), said: 'This is excellent news and a landmark moment for sexual health in England.
'A new gonorrhoea vaccination programme – alongside continued rollout of mpox vaccination – forms a vital part of our efforts to address the significant inequalities we are seeing in sexual health outcomes.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
36 minutes ago
- BBC News
NHS plans to DNA test all babies in England to assess disease risk
Every newborn baby in England will have their DNA mapped to assess their risk of hundreds of diseases, under NHS plans for the next 10 scheme, first reported by the Daily Telegraph, is part of a government drive towards predicting and preventing illness, which will also see £650m invested in DNA research for all patients by Secretary Wes Streeting said gene technology would enable the health service to "leapfrog disease, so we're in front of it rather than reacting to it".It comes after a study analysing the genetic code of up to 100,000 babies was announced in October. The government's 10-year plan for the NHS, which is set to be revealed over the next few weeks is aimed at easing pressure on Department for Health and Social Care said that genomics - the study of genes - and AI would be used to "revolutionise prevention" and provide faster diagnoses and an "early warning signal for disease".Screening newborn babies for rare diseases will involve sequencing their complete DNA using blood samples from their umbilical are approximately 7,000 single gene disorders. The NHS study which began in October only looked for gene disorders that develop in early childhood and for which there are effective newborn babies are only given a heelprick blood test that checks for nine serious conditions, including cystic health secretary said in a statement: "With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill-health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives."
Daily Mirror
an hour ago
- Daily Mirror
Bradley Walsh shares health struggle 'people think I'm making up'
The Chase host's condition leaves him 'white as a sheet' Bradley Walsh is a hugely familiar face on TV with his career having gone from strength to strength in recent years. The 65-year-old will be back on our screens this evening for an instalment of The Chase Celebrity Special. He has also recently appeared on Bradley and Barney Walsh: Breaking Dad, an ITV travel series that sees Bradley joined by son Barney. In one episode, they discovered Tokyo's vibrant attractions and, according to Bradley, some of Japan's most hair-raising rope bridges. During a recent appearance on Chris Evans' Virgin Radio Breakfast Show, Bradley confessed to experiencing genuine vertigo while navigating the precarious structure. Bradley told Chris: "I know, people think I'm making it up." However, Chris replied: "There's no way, you were white as a sheet", and Barney interjected with: "It does terrify him". Reassuringly, Bradley reported that he's been making progress with his vertigo struggles, stating: "I'd like to think that since the early days, I've got a bit better." The NHS website describes vertigo as a sensation of spinning, either personally or environmentally, which can significantly impact balance. It notes that vertigo episodes can last from mere seconds to hours, with severe cases persisting for days or even months, as reported by Gloucestershire Live. Vertigo often resolves itself without treatment. Nevertheless, the NHS advises consulting a GP if symptoms recur or interfere with daily life. Vertigo is often mistakenly referred to as a fear of heights when in actuality, this should be termed acrophobia. According to Healthline, acrophobia can induce physical reactions such as increased sweating, chest tightness or pain, nausea or dizziness, and an accelerated heartbeat when faced with or even just thinking about elevated places. Beyond his "vertigo", Bradley has also grappled with another medical condition called blepharitis, leading to swollen, red eyes. He previously said: "People don't realise I have seriously bad blepharitis. "I have to take one pill a day for it or I really struggle. I am going to need my eyes operated on at some point to sort it out. So many times, people have commented on how I look. But they don't realise. If I take medication though, I'm fine."
Daily Mirror
an hour ago
- Daily Mirror
GP shares the £10 Boots item that can 'eliminate' summer chafing
Shoppers said they experienced 'no chafing at all' once using this 'liberating' roll-on product With a heatwave baking parts of the UK this weekend, Brits may be experiencing some uncomfortable feelings down below when sweaty skin rubs against clothes. This can lead to painful problems, especially for those with sensitive skin. Dr Raj Arora, an NHS GP with expertise in women's health, shared an Instagram video with a product that hundreds of women "swear by" during the hot summer months. She said: "Chafing is really common, especially in the summer when you're wearing shorts and your thighs are rubbing. There's no shame in it; it happens to all of us." "You can get this called Megababe. This contains aloe vera, vitamin E. It hydrates the skin, comes in a roll-on. Just pop it in your bag and reapply." The Thigh Rescue product is available in Boots stores and, at the time of writing, the 60ml pack (normally £12) is discounted to £9.60 in a 20% off sale. There are similar products available elsewhere such as Lanacane Anti-Chafing Gel (£7.99 at Superdrug) and KKwoter's Anti Chafe Stick (£5.99 from Amazon). But, the anti-friction stick by Megababe has lots of glowing reviews as well from over 1,550 customers. One said: "I wish I'd found it years ago as it is amazing. Used it on holiday and got no chafing at all!" Another added: "Glides on easily with no visible residue and no scent. I could have reapplied but didn't need to. I will keep this for future sweaty walks or any other needs!" Someone else shared how the product has "changed my life." They wrote: "The first time I used this, I was anxious because I didn't see how it could work for me when nothing else had. I did 10,000+ steps that day and didn't have to reapply - I was amazed. "I now use it as religiously as deodorant. It's liberating to not have to wear shorts under every outfit after wearing them for years. It's silly but I always felt the shorts were something I had to wear as a fat person and I just wished I could go outside without them, and now I can!" And, one more commented: "This is seriously the best product, it keeps my skin healthy and protected from chafe and rash. I recommend this to friends all the time!" A few people had issues, as one reported: "The formula doesn't seem to take into account sweat and high temperatures, only friction. It wears off after 15 minutes." Another claimed it "did not work at all." The NHS recommends consulting a doctor if you experience persistent, recurrent, or severe symptoms of chafing. They may recommend further tests or treatments, including topical corticosteroids or antibiotics
